Primary ciliary dyskinesia overview

Jump to navigation Jump to search

Primary ciliary dyskinesia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Primary ciliary dyskinesia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Interventions

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Primary ciliary dyskinesia overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Primary ciliary dyskinesia overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Primary ciliary dyskinesia overview

CDC on Primary ciliary dyskinesia overview

Primary ciliary dyskinesia overview in the news

Blogs on Primary ciliary dyskinesia overview

Directions to Hospitals Treating Primary ciliary dyskinesia

Risk calculators and risk factors for Primary ciliary dyskinesia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Hafsa Ghaffar, M.B.B.S[2]

Overview

Primary ciliary dyskinesiaPCD is an autosomal recessive disorder characterized by functional defects in the cilia resulting in an abnormal mucociliary clearance.Epithelial cells containing motile cilia are localised in the respiratory tree, oviduct, sperms, ventricles of the brain and embryonic node. Defects in the epithelial cells accounts for the majority of symptoms of PCD including sinusitis, otitis media and bronchiectasis. Situs inverses(in some patients) and rarely hydrocephalus. While the understanding of the cellular and molecular mechanisms responsible for these symptoms has progressed recently, genetic analysis has identified mutations in only two axonemal dynein genes that can account for abnormal cilia structure.Nasal nitric oxide Nno is the screening test that could be performed initially to diagnose PCD initially followed by electron microscopy to confirm the diagnosis. Treatment mainly focuses on treating underlying conditions that can exacerbate PCD such as antibiotics for rhinosinusitis, bronchiectasis, and sinusitis.

Historical Perspective

In 1981, Rossman and coworkers came up with the term primary ciliary dyskinesia (PCD) because some patients with Kartagener syndrome had cilia that were not immotile but exhibited an uncoordinated and inefficient movement pattern.

Classification

There is no established system for the classification of primary ciliary dyskinesia.

Pathophysiology

In many people with primary ciliary dyskinesia, the cause of the disease is unknown, but the main factor contributing to the pathogenesis is mutations in the proteins forming the cilia which result in the formation of abnormal or immotile cilia. Clearly, cilia have many important functions within the body, defects in these cell structures cause a variety of signs and symptoms

Causes

There are no established causes for Primary ciliary dyskinesia.PCD is related to defects in mucociliary clearance due to abnormal ciliary structure. Mutations in around 46 different genes throughout the genome have been found to be causative. Some of these include DNAH5, CCDC39, DNAI1, CCDC40, DNAH11, ZMYND10, CCDC103, CCDC151 and ARMC4.

Differentiating Primary ciliary dyskinesia from Other Diseases

Primary ciliary dyskinesia must be differentiated from other conditions that cause infertility, sinusitis, otitis media, and rhinitis.

Epidemiology and Demographics

Primary ciliary dyskinesia (PCD) is generally documented as etiology of bronchiectasis not only in children or young adults but also in older patients. It is challenging to demonstrate the prevalence of PCD in diverse population with estimates varying between one in 4000 to one in 40,000. PCD is linked with the high levels of consanguinity. Clinical suspicion of PCD is high in these communities, chronic cough and nasal symptoms should rise concern for prompt diagnostic testing.

Risk Factors

There are no established risk factors for primary ciliary dyskinesia.

Screening

There is insufficient evidence to recommend routine screening for primary ciliary dyskinesia, however patients with persistent sinusitis, rhinitis, and no known etiology should be screened by nasal nitric oxide test, low levels of nasal nitric oxide is diagnostic of primary ciliary dyskinesia and should prompt further testing with biopsy and ciliary beat pattern(CBP).

Natural History, Complications, and Prognosis

The long-term effects of primary ciliary dyskinesia (PCD) are dependent on respiratory symptoms. PCD is not considered to be life-threatening, but persistent lung and airway disease can lead to permanent damage. Recurrent ear infections can lead to hearing loss, which is sometimes permanent, prompt diagnosis and early treatment improve long-term outcomes.

Diagnosis

A high level of suspicion is required to warrant early diagnosis and initiation of appropriate management before irreversible lung damage ensues. Diagnostic investigations are complex, requiring expensive arrangements and an experienced team of clinicians and scientists. People with persistent respiratory symptoms such as rhinitis, rhino-sinusitis, infertility, recurrent otitis media should seek medical care and undergo further testing. Nasal nitric oxide levels are low in PCD and should be performed as a screening test. Transmission electron microscopy to assess the ultrastructure of cilia is another important investigation that can confirm the diagnosis.

Diagnostic Study of Choice

There is no single diagnostic test for primary ciliary dyskinesia. A combination of the following techniques could contribute to the diagnosis of Primary ciliary dyskinesia.

  • Nasal nitric oxide test (nNo)
  • Assessment of ciliary ultrastructure by Transmission Electron Microscopy(TEM), Gold standard.
  • Ciliary beat frequency CBF and Ciliary beat pattern CBP.
  • Radio-aerosol MCC
  • Direct video cinematography or oscillography to analyse ciliary beat waveform.
  • Bronchial ciliary biopsy.
  • Electron microscopy Tomography.
  • Semen analysis.

History and Symptoms

Patients with primary ciliary dyskinesia may present in early infancy with respiratory distress or later in life with chronic bronchitis, persistent rhinorrhea, sinusitis, bronchiectasis, or male infertility.

Physical Examination

Primary ciliary dyskinesia has no characteristic physical examination findings, however, any clue to recurrent sinus infections or respiratory distress should raise concern for diagnosing primary ciliary dyskinesia.

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

There are no definite treatment options, the goal is to manage associated conditions that can lead to worsening of PCD.

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

References

Template:WH Template:WS